Objective: The aim of this study was the scientific evaluation of an intradermal vaccination method in comparison to an intramuscular vaccination against in suckling piglets with regard to skin reactions, performance parameters and procedural aspects. Possible effects on animal welfare should be deduced.
Material And Methods: Under field conditions, 672 suckling piglets in three batches were vaccinated; 338 intradermally and 334 intramuscularly. In addition to a detailed scoring of the integument, the injection site with the local reaction was evaluated, scoring the swelling size (score 0-5), and rubor and incrustation (score 0-3). Moreover, piglets were weighed individually 1 day before vaccination and 8 days later. In addition, the time required for each vaccination was documented.
Results: On the first day after vaccination, 71.3 % of the intramuscularly vaccinated piglets and 2.7 % of the intradermally vaccinated piglets displayed no swelling at the vaccination site. No differences remained by the 7th day after vaccination. Daily weight gain did not differ significantly between the piglets in the intramuscularly (248 g) and intradermally (258 g) vaccinated groups. Intradermal vaccination took a mean of 11 seconds per piglet, while 17 seconds were required for intramuscular vaccination.
Conclusions And Clinical Relevance: In this first study, no negative effects of the intradermal vaccination on performance parameters and no long-standing skin reactions were detected in the suckling piglets. Skin reactions were related to the desired immune reaction of the intradermal vaccination, but were no longer present after 7 days. Moreover, with regard to procedural aspects, the intradermal vaccination offered time saving advantages. To evaluate further possible effects on animal welfare, further analyses via video recordings are required.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.15653/TPG-180461 | DOI Listing |
J Control Release
January 2025
Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China. Electronic address:
Cancer vaccines hold great promise in the fight against cancer. Here, we report an ice-pop making inspired photothermal ultra-swelling microneedle (PUSMN) patch for facilitating and enhancing cancer vaccination. The PUSMN patch consist of an array of microneedles made from photo-crosslinked methacrylated hyaluronic acid and polydopamine, a near-infrared photothermal conversion material, connected to a customized resin handle like an ice-pop stick.
View Article and Find Full Text PDFTrans R Soc Trop Med Hyg
January 2025
Department of Medical Parasitology, Medical school, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 6135715794, Iran.
Background: Leishmaniasis represents a significant parasitic disease with global health implications, and the development of an affordable and effective vaccine could provide a valuable solution. This study aimed to evaluate the immunogenicity of a DNA vaccine targeting Leishmania major specifically based on the Leishmania-activated C kinase (LACK) antigen, utilizing calcium phosphate nanoparticles (CaPNs) and chitosan nanoparticles (ChitNs) as adjuvants.
Methods: Seventy female BALB/c mice, aged 4-6 wk and weighing 20-22 g, were selected and divided into five groups, each consisting of 14 mice.
Sci Adv
January 2025
Department of Biological Engineering, MIT, Cambridge, MA, USA.
Intradermal Bacillus Calmette-Guérin (BCG) is the most widely administered vaccine, but it does not sufficiently protect adults against pulmonary tuberculosis. Recent studies in nonhuman primates show that intravenous BCG administration offers superior protection against (). We used single-cell analysis of bronchoalveolar lavage cells from rhesus macaques vaccinated via different routes and doses of BCG to identify alterations in the immune ecosystem in the airway following vaccination.
View Article and Find Full Text PDFGels
December 2024
State Key Laboratory of Digital Medical Engineering, Basic Medicine Research and Innovation Center of Ministry of Education, Southeast University, Nanjing 211102, China.
Tumor whole-cell vaccines are designed to introduce a wide range of tumor-associated antigens into the body to counteract the immunosuppression caused by tumors. In cases of lymphoma of which the specific antigen is not yet determined, the tumor whole-cell vaccine offers distinct advantages. However, there is still a lack of research on an effective preparation method for the lymphoma whole-cell vaccine.
View Article and Find Full Text PDFBiomaterials
December 2024
Center for Inflammation, Immunity & Infection, Institute for Biomedical Science, Georgia State University, Atlanta, GA, USA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!